MYCN and neuroblastoma: Conversely, N-Myc, a differentiation inhibitor 31,32,46 and major unfavorable prognosis marker in neuroblastoma, was reduced by either RA or NEN, with the combination group showing the most significant reduction (Fig. 5D, S5A).